We serve Chemical Name:N,N,N-Triethylethanaminium cyanide CAS:13435-20-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N,N,N-Triethylethanaminium cyanide
CAS.NO:13435-20-6
Synonyms:MFCD00066552;N,N,N-Triethylethanaminium cyanide;Tetraethylammonium cyanide;tetraethylammonium;triethylammonium cyanide;EINECS 236-566-2;tetraethylazanium cyanide
Molecular Formula:C9H20N2
Molecular Weight:156.268
HS Code:2926909090
Physical and Chemical Properties:
Melting point:250ºC (dec.)(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:23.79000
Exact Mass:156.162643
LogP:1.97918
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811 6.1/PG 2
Packing Group:III
Contact us for information like MFCD00066552 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tetraethylazanium cyanide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,triethylammonium cyanide Use and application,tetraethylazanium cyanide technical grade,usp/ep/jp grade.
Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. N,N,N-Triethylethanaminium cyanide manufacturer Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated. N,N,N-Triethylethanaminium cyanide supplier Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations. N,N,N-Triethylethanaminium cyanide vendor Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. N,N,N-Triethylethanaminium cyanide factory Without disclosing or confirming the number of vaccine doses, the FDA said in a news release that it had authorized two batches of the vaccine for use, that several other batches were not suitable for use and that others were being evaluated.
